Report

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 30
1.3 INCLUSIONS & EXCLUSIONS 30
1.4 MARKET SCOPE 31
1.4.1 MARKETS COVERED 31
1.5 YEARS CONSIDERED 32
1.6 CURRENCY CONSIDERED 32
1.7 MARKET STAKEHOLDERS 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.2 RESEARCH DESIGN 34
2.2.1 SECONDARY RESEARCH 34
2.2.1.1 Key data from secondary sources 36
2.2.2 PRIMARY RESEARCH 36
2.2.2.1 Primary sources 37
2.2.2.2 Key industry insights 38
2.2.2.3 Breakdown of primaries 38
2.3 MARKET SIZE ESTIMATION 39
2.3.1 BOTTOM-UP APPROACH 40
2.3.1.1 Approach 1: Company revenue estimation approach 41
2.3.1.2 Approach 2: Customer-based market estimation 41
2.3.1.3 Approach 3: Top-down approach 42
2.3.1.4 Approach 4: Primary interviews 42
2.4 DATA TRIANGULATION & MARKET BREAKDOWN 44
2.5 MARKET SHARE ASSESSMENT 46
2.6 STUDY ASSUMPTIONS 46
2.7 ASSUMPTIONS 46
2.8 RISK ASSESSMENT 48
2.9 RESEARCH LIMITATIONS 49
3 EXECUTIVE SUMMARY 50
?
4 PREMIUM INSIGHTS 54
4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET OVERVIEW 54
4.2 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION,
2024 VS. 2029 (USD MILLION) 55
4.3 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION AND END USER,
2023 (USD MILLION) 56
4.4 GEOGRAPHIC GROWTH OPPORTUNITIES 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
5.2.1 DRIVERS 59
5.2.1.1 Emergence of predictive analytics in ICE technology 59
5.2.1.2 Expanding clinical use cases of ICE technology 60
5.2.1.3 Ongoing integration of ICE technology with other imaging modalities 61
5.2.1.4 Rising prevalence of cardiac disorders 62
5.2.2 RESTRAINTS 63
5.2.2.1 Premium product pricing 63
5.2.2.2 Dearth of healthcare professionals 63
5.2.3 OPPORTUNITIES 64
5.2.3.1 Broadening clinical applications of ICE in structural heart disease interventions 64
5.2.3.2 Advances in 3D and real-time 3D (4D) imaging 65
5.2.4 CHALLENGES 65
5.2.4.1 Technical limitations 65
5.2.4.2 Increased pricing pressure on market players 65
5.3 PORTER'S FIVE FORCES ANALYSIS 66
5.3.1 THREAT OF NEW ENTRANTS 68
5.3.2 THREAT OF SUBSTITUTES 68
5.3.3 BARGAINING POWER OF SUPPLIERS 68
5.3.4 BARGAINING POWER OF BUYERS 68
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.4 REGULATORY ANALYSIS 69
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.4.2 KEY REGULATORY GUIDELINES 73
5.4.2.1 North America 73
5.4.2.1.1 US 73
5.4.2.1.2 Canada 74
5.4.2.2 Europe 74
?
5.4.2.3 Asia Pacific 75
5.4.2.3.1 Japan 75
5.4.2.3.2 India 76
5.4.2.3.3 China 76
5.5 REIMBURSEMENT SCENARIO 77
5.6 ECOSYSTEM ANALYSIS 79
5.7 INVESTMENT & FUNDING SCENARIO 79
5.8 TECHNOLOGY ANALYSIS 81
5.8.1 KEY TECHNOLOGIES 81
5.8.1.1 Phased-array ICE 81
5.8.1.2 Rotational ICE 81
5.8.1.3 Doppler imaging 82
5.8.1.4 3D ICE technology 82
5.8.2 COMPLEMENTARY TECHNOLOGIES 82
5.8.2.1 Intravascular ultrasound (IVUS) 82
5.8.2.2 Value-added software (AI and IoT) 82
5.8.2.3 Clinical decision support systems 83
5.8.2.4 Electrophysiology (EP) mapping systems 83
5.8.3 ADJACENT TECHNOLOGIES 83
5.8.3.1 Event monitors 83
5.8.3.2 Holter monitors 83
5.9 VALUE CHAIN ANALYSIS 84
5.9.1 RESEARCH & DEVELOPMENT 84
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT 84
5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 84
5.10 SUPPLY CHAIN ANALYSIS 85
5.10.1 PROMINENT COMPANIES 85
5.10.2 SMALL & MEDIUM-SIZED ENTERPRISES 86
5.10.3 END USERS 86
5.11 PRICING ANALYSIS 87
5.12 PATENT ANALYSIS 91
5.13 TRADE ANALYSIS 92
5.14 KEY CONFERENCES & EVENTS, 2024-2025 93
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 95
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 95
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
5.16.2 BUYING CRITERIA 96
5.17 ADJACENT MARKET ANALYSIS 98
5.18 UNMET NEEDS & KEY PAIN POINTS 98
5.19 ARTIFICIAL INTELLIGENCE IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) 99
?
6 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT 100
6.1 INTRODUCTION 101
6.2 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE 101
6.2.1 2D ULTRASOUND SYSTEMS 102
6.2.1.1 Increasing integration of modern ICE systems with other diagnostic systems to drive market growth 102
6.2.2 3D/4D ULTRASOUND SYSTEMS 103
6.2.2.1 Increasing incidence of cardiovascular diseases worldwide to drive growth 103
6.2.3 DOPPLER ULTRASOUND SYSTEMS 104
6.2.3.1 Higher resolution imaging and advanced Doppler techniques to enhance capability of ICE systems 104
6.3 ICE CATHETERS 105
6.3.1 DOPPLER ICE CATHETERS 106
6.3.1.1 Growing preference for minimally invasive cardiac procedures to support market growth 106
6.3.2 PHASED-ARRAY ICE CATHETERS 107
6.3.2.1 High cost and limited applications to restrict market growth 107
6.3.3 FIXED-ARRAY ICE CATHETERS 108
6.3.3.1 High demand for advanced cardiac imaging solutions to drive innovation and adoption of fixed-array catheters 108
6.3.4 MECHANICAL ROTATIONAL ICE CATHETERS 109
6.3.4.1 Innovations in catheter technology to boost market growth 109
6.4 ICE CONSOLES 110
6.4.1 CART/TROLLEY-BASED CONSOLES 111
6.4.1.1 Rising geriatric population to fuel market growth 111
6.4.2 HANDHELD/PORTABLE CONSOLES 112
6.4.2.1 Increasing adoption of portable consoles in healthcare facilities to drive market growth 112
6.5 GUIDING CATHETERS & SHEATHS 112
6.5.1 INCREASING INTEGRATION OF GUIDING CATHETERS & SHEATHS WITH PORTABLE ICE CONSOLES TO PROPEL MARKET GROWTH 112
6.6 DISPOSABLE ACCESSORIES 113
6.6.1 COST OF DISPOSABLE ACCESSORIES TO PLAY SIGNIFICANT ROLE IN DRIVING MARKET GROWTH 113
6.7 SOFTWARE 114
6.7.1 INCREASING ADOPTION OF PREDICTIVE ANALYTICS FOR REAL-TIME IMAGING TO BOOST MARKET 114
?
7 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION 115
7.1 INTRODUCTION 116
7.2 STRUCTURAL HEART DEFECTS 116
7.2.1 MITRAL VALVE REPAIR/REPLACEMENT 117
7.2.1.1 Growing burden of cardiovascular diseases to drive market 117
7.2.2 AORTIC VALVE REPLACEMENT 119
7.2.2.1 Growing demand for effective imaging tools like ICE to boost market 119
7.2.3 OTHER STRUCTURAL HEART DEFECTS 120
7.3 ELECTROPHYSIOLOGY 120
7.3.1 GROWING INTEGRATION OF ICE WITH MAPPING SYSTEMS TO DRIVE MARKET GROWTH 120
7.4 LEFT ATRIAL APPENDAGE CLOSURE 121
7.4.1 BENEFITS SUCH AS MINIMIZATION OF RADIATION EXPOSURE IN PROCEDURES LIKE LAA CLOSURE TO SUPPORT GROWTH 121
7.5 CARDIAC MONITORING 122
7.5.1 BETTER CLINICAL DECISION-MAKING AND IMPROVED PATIENT OUTCOMES TO SUPPORT SEGMENT GROWTH 122
7.6 OTHER APPLICATIONS 123
8 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER 125
8.1 INTRODUCTION 126
8.2 HOSPITALS & SURGICAL CENTERS 126
8.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF ICE TECHNOLOGIES TO BOOST MARKET 126
8.3 AMBULATORY SURGICAL CENTERS 127
8.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE GROWTH 127
8.4 HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS 128
8.4.1 GROWING USE OF ICE IN CATH LABS FOR MINIMALLY INVASIVE CARDIAC PROCEDURES TO BOOST MARKET 128
8.5 INDEPENDENT DIAGNOSTIC CENTERS 129
8.5.1 SPECIALIZED EXPERTISE AND ADVANCED ICE TECHNOLOGY IN INDEPENDENT DIAGNOSTIC CENTERS TO BOOST GROWTH 129
8.6 OTHER END USERS 130
9 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION 132
9.1 INTRODUCTION 133
9.2 NORTH AMERICA 134
9.2.1 US 138
9.2.1.1 Growing number of FDA approvals for ICE devices to support market growth 138
9.2.2 CANADA 140
9.2.2.1 Growing public-private funding for research to drive market growth 140
?
9.3 EUROPE 143
9.3.1 GERMANY 148
9.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth 148
9.3.2 UK 150
9.3.2.1 Increasing public & private investments to contribute to market growth 150
9.3.3 FRANCE 152
9.3.3.1 Statutory health insurance system to support market growth 152
9.3.4 ITALY 154
9.3.4.1 Rising incidence of cardiac diseases to drive adoption of ICE devices 154
9.3.5 SPAIN 156
9.3.5.1 Growing number of surgical procedures to drive market growth in Spain 156
9.3.6 REST OF EUROPE 158
9.4 ASIA PACIFIC 160
9.4.1 JAPAN 165
9.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth 165
9.4.2 CHINA 168
9.4.2.1 Growing focus of local and international market players to favor market growth 168
9.4.3 INDIA 170
9.4.3.1 Increasing government-implemented healthcare initiatives to support market growth 170
9.4.4 AUSTRALIA 173
9.4.4.1 R&D tax incentive program to support market growth 173
9.4.5 SOUTH KOREA 175
9.4.5.1 Supportive government initiatives to drive market growth 175
9.4.6 REST OF ASIA PACIFIC 177
9.5 LATIN AMERICA 179
9.5.1 BRAZIL 183
9.5.1.1 Brazil to dominate LATAM market 183
9.5.2 MEXICO 185
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 185
9.5.3 REST OF LATIN AMERICA 187
9.6 MIDDLE EAST & AFRICA 190
9.6.1 GCC COUNTRIES 194
9.6.1.1 Developments in healthcare infrastructure and high government expenditure to drive market 194
9.6.2 REST OF MIDDLE EAST & AFRICA 196
?
10 COMPETITIVE LANDSCAPE 199
10.1 INTRODUCTION 199
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 199
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET 199
10.3 REVENUE ANALYSIS 201
10.4 MARKET SHARE ANALYSIS 202
10.4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SHARE, BY KEY PLAYER, 2023 202
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 205
10.5.1 STARS 205
10.5.2 EMERGING LEADERS 205
10.5.3 PERVASIVE PLAYERS 205
10.5.4 PARTICIPANTS 205
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 207
10.5.5.1 Company footprint 207
10.5.5.2 Product footprint 208
10.5.5.3 Application footprint 209
10.5.5.4 End-user footprint 210
10.5.5.5 Region footprint 211
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 212
10.6.1 PROGRESSIVE COMPANIES 212
10.6.2 RESPONSIVE COMPANIES 212
10.6.3 DYNAMIC COMPANIES 212
10.6.4 STARTING BLOCKS 212
10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023 214
10.7 COMPANY VALUATION AND FINANCIAL METRICS 216
10.8 PRODUCT/BRAND COMPARISON 217
10.9 COMPETITIVE SCENARIO 218
10.9.1 PRODUCT LAUNCHES AND APPROVALS 218
10.9.2 DEALS 219
11 COMPANY PROFILES 220
11.1 KEY PLAYERS 220
11.1.1 MEDTRONIC 220
11.1.1.1 Business overview 220
11.1.1.2 Products offered 222
11.1.1.3 Recent developments 223
11.1.1.3.1 Product approvals 223
11.1.1.3.2 Deals 224
?
11.1.1.4 MnM view 224
11.1.1.4.1 Key strengths 224
11.1.1.4.2 Strategic choices 224
11.1.1.4.3 Weaknesses and competitive threats 224
11.1.2 ABBOTT 225
11.1.2.1 Business overview 225
11.1.2.2 Products offered 226
11.1.2.3 Recent developments 227
11.1.2.3.1 Product launches and approvals 227
11.1.2.3.2 Deals 228
11.1.2.4 MnM view 228
11.1.2.4.1 Key strengths 228
11.1.2.4.2 Strategic choices 228
11.1.2.4.3 Weaknesses and competitive threats 229
11.1.3 SIEMENS HEALTHINEERS AG 230
11.1.3.1 Business overview 230
11.1.3.2 Products offered 231
11.1.3.3 Recent developments 232
11.1.3.3.1 Product launches and approvals 232
11.1.3.4 MnM view 233
11.1.3.4.1 Key strengths 233
11.1.3.4.2 Strategic choices 233
11.1.3.4.3 Weaknesses and competitive threats 233
11.1.4 GE HEALTHCARE 234
11.1.4.1 Business overview 234
11.1.4.2 Products offered 235
11.1.4.3 Recent developments 236
11.1.4.3.1 Product approvals 236
11.1.4.3.2 Deals 237
11.1.4.4 MnM view 237
11.1.4.4.1 Key strengths 237
11.1.4.4.2 Strategic choices 237
11.1.4.4.3 Weaknesses and competitive threats 238
11.1.5 BOSTON SCIENTIFIC CORPORATION 239
11.1.5.1 Business overview 239
11.1.5.2 Products offered 240
11.1.5.3 Recent developments 241
11.1.5.3.1 Product launches 241
11.1.5.3.2 Deals 241
11.1.5.3.3 Expansions 242
?
11.1.5.4 MnM view 242
11.1.5.4.1 Key strengths 242
11.1.5.4.2 Strategic choices 242
11.1.5.4.3 Weaknesses and competitive threats 242
11.1.6 PHILIPS HEALTHCARE 243
11.1.6.1 Business overview 243
11.1.6.2 Products offered 244
11.1.6.3 Recent developments 245
11.1.6.3.1 Product launches and approvals 245
11.1.6.3.2 Deals 246
11.1.6.3.3 Expansions 246
11.1.6.4 MnM view 247
11.1.6.4.1 Key strengths 247
11.1.6.4.2 Strategic choices 247
11.1.6.4.3 Weaknesses and competitive threats 247
11.1.7 JOHNSON & JOHNSON MEDTECH 248
11.1.7.1 Business overview 248
11.1.7.2 Products offered 249
11.1.7.3 Recent developments 250
11.1.7.3.1 Product launches and approvals 250
11.1.7.3.2 Deals 251
11.1.7.4 MnM view 251
11.1.7.4.1 Key strengths 251
11.1.7.4.2 Strategic choices 251
11.1.7.4.3 Weaknesses and competitive threats 251
11.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 252
11.1.8.1 Business overview 252
11.1.8.2 Products offered 253
11.1.8.3 Recent developments 254
11.1.8.3.1 Product launches 254
11.1.8.3.2 Deals 254
11.1.9 EDWARDS LIFESCIENCES CORPORATION 255
11.1.9.1 Business overview 255
11.1.9.2 Products offered 256
11.1.10 CANON MEDICAL SYSTEMS CORPORATION 258
11.1.10.1 Business overview 258
11.1.10.2 Products offered 259
11.1.10.3 Recent developments 260
11.1.10.3.1 Product launches 260
11.1.10.3.2 Deals 260
?
11.1.11 FUJIFILM HOLDINGS CORPORATION 261
11.1.11.1 Business overview 261
11.1.11.2 Products offered 262
11.1.11.3 Recent developments 263
11.1.11.3.1 Product launches 263
11.1.11.3.2 Deals 263
11.1.12 GUERBET 264
11.1.12.1 Business overview 264
11.1.12.2 Products offered 265
11.1.12.3 Recent developments 266
11.1.12.3.1 Deals 266
11.1.13 TERUMO CORPORATION 267
11.1.13.1 Business overview 267
11.1.13.2 Products offered 268
11.1.13.3 Recent developments 269
11.1.13.3.1 Deals 269
11.1.14 LIVANOVA 270
11.1.14.1 Business overview 270
11.1.14.2 Products offered 271
11.1.15 INFRAREDX INC. 272
11.1.15.1 Business overview 272
11.1.15.2 Products offered 272
11.1.16 STEREOTAXIS, INC. 273
11.1.16.1 Business overview 273
11.1.16.2 Products offered 274
11.1.16.3 Recent developments 274
11.1.16.3.1 Deals 274
11.1.17 B. BRAUN SE 275
11.1.17.1 Business overview 275
11.1.17.2 Products offered 276
11.1.18 ESAOTE SPA 277
11.1.18.1 Business overview 277
11.1.18.2 Products offered 277
11.1.18.3 Recent developments 278
11.1.18.3.1 Product launches 278
11.2 OTHER PLAYERS 279
11.2.1 CHISON MEDICAL TECHNOLOGIES CO., LTD. 279
11.2.2 SHIFAMED, LLC 280
11.2.3 CONAVI MEDICAL INC. 281
11.2.4 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD. 281
11.2.5 BK MEDICAL 282
11.2.6 BENQ MEDICAL TECHNOLOGY 283
11.2.7 ECHONOUS INC. 283
11.2.8 VOLTA MEDICAL 284
11.2.9 TRIVITRON HEALTHCARE 285
11.2.10 ECHOPIXEL 286
11.2.11 CATHVISION 287
11.2.12 PIE MEDICAL IMAGING BV 288
12 APPENDIX 289
12.1 DISCUSSION GUIDE 289
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 294
12.3 CUSTOMIZATION OPTIONS 296
12.4 RELATED REPORTS 296
12.5 AUTHOR DETAILS 298

TABLE 1 LIMITATIONS AND ASSOCIATED RISKS 48
TABLE 2 STUDIES ON AI IN ECHOCARDIOGRAPHIC DIAGNOSTICS 60
TABLE 3 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PORTER'S FIVE FORCES ANALYSIS 67
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 72
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 72
TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT 73
TABLE 10 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 73
TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 74
TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 75
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 76
TABLE 14 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 77
TABLE 15 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2023 89
TABLE 16 IMPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019-2023 (USD THOUSAND) 92
TABLE 17 EXPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019-2023 (USD THOUSAND) 93
TABLE 18 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024-2025 94
TABLE 19 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES 96
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 97
TABLE 21 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: UNMET CUSTOMER NEEDS & KEY PAIN POINTS 98
TABLE 22 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 101
TABLE 23 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 102
TABLE 24 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY REGION, 2022-2029 (USD MILLION) 102
TABLE 25 2D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION) 103
TABLE 26 3D/4D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION) 104
TABLE 27 DOPPLER ULTRASOUND SYSTEMS MARKET, BY REGION,
2022-2029 (USD MILLION) 105
TABLE 28 ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 105
TABLE 29 ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION) 106
TABLE 30 DOPPLER ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION) 107
TABLE 31 PHASED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION) 108
TABLE 32 FIXED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION) 109
TABLE 33 MECHANICAL ROTATIONAL ICE CATHETERS MARKET, BY REGION,
2022-2029 (USD MILLION) 110
TABLE 34 ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 110
TABLE 35 ICE CONSOLES MARKET, BY REGION, 2022-2029 (USD MILLION) 111
TABLE 36 CART/TROLLEY-BASED CONSOLES MARKET, BY REGION,
2022-2029 (USD MILLION) 111
TABLE 37 HANDHELD/PORTABLE CONSOLES MARKET, BY REGION,
2022-2029 (USD MILLION) 112
TABLE 38 GUIDING CATHETERS & SHEATHS MARKET, BY REGION,
2022-2029 (USD MILLION) 113
TABLE 39 ICE DISPOSABLE ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION) 113
TABLE 40 ICE SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION) 114
TABLE 41 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 116
TABLE 42 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION) 117
TABLE 43 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY REGION, 2022-2029 (USD MILLION) 117
TABLE 44 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR MITRAL VALVE REPAIR/REPLACEMENT, BY REGION, 2022-2029 (USD MILLION) 118
TABLE 45 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR AORTIC VALVE REPLACEMENT, BY REGION, 2022-2029 (USD MILLION) 119
TABLE 46 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER STRUCTURAL HEART DEFECTS, BY REGION, 2022-2029 (USD MILLION) 120
TABLE 47 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR ELECTROPHYSIOLOGY,
BY REGION, 2022-2029 (USD MILLION) 121
TABLE 48 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR LEFT ATRIAL APPENDAGE CLOSURE, BY REGION, 2022-2029 (USD MILLION) 122
TABLE 49 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR CARDIAC MONITORING, BY REGION, 2022-2029 (USD MILLION) 123
TABLE 50 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER APPLICATIONS,
BY REGION, 2022-2029 (USD MILLION) 124
TABLE 51 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION) 126
TABLE 52 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION) 127
TABLE 53 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION) 128
TABLE 54 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS, BY REGION, 2022-2029 (USD MILLION) 129
TABLE 55 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION) 130
TABLE 56 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER END USERS,
BY REGION, 2022-2029 (USD MILLION) 131
TABLE 57 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION,
2022-2029 (USD MILLION) 133
TABLE 58 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 135
TABLE 59 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 135
TABLE 60 NORTH AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 136
TABLE 61 NORTH AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 136
TABLE 62 NORTH AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 136
TABLE 63 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 137
TABLE 64 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION) 137
TABLE 65 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY END USER, 2022-2029 (USD MILLION) 138
TABLE 66 US: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 139
TABLE 67 US: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 139
TABLE 68 US: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 140
TABLE 69 US: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 140
TABLE 70 CANADA: RESEARCH GRANTS IN INTRACARDIAC ECHOCARDIOGRAPHY 141
TABLE 71 CANADA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 142
TABLE 72 CANADA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 142
TABLE 73 CANADA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 143
TABLE 74 CANADA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 143
TABLE 75 EUROPE: PRODUCT APPROVALS IN INTRACARDIAC ECHOCARDIOGRAPHY 144
TABLE 76 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 77 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 145
TABLE 78 EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 145
TABLE 79 EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 146
TABLE 80 EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 146
TABLE 81 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 147
TABLE 82 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION) 147
TABLE 83 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION) 148
TABLE 84 GERMANY: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 149
TABLE 85 GERMANY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 149
TABLE 86 GERMANY: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 150
TABLE 87 GERMANY: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 150
TABLE 88 UK: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 151
TABLE 89 UK: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 151
TABLE 90 UK: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 152
TABLE 91 UK: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 152
TABLE 92 FRANCE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 153
TABLE 93 FRANCE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 153
TABLE 94 FRANCE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 154
TABLE 95 FRANCE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 154
TABLE 96 ITALY: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 155
TABLE 97 ITALY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 155
TABLE 98 ITALY: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 156
TABLE 99 ITALY: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 156
TABLE 100 SPAIN: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 157
TABLE 101 SPAIN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 157
TABLE 102 SPAIN: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 158
TABLE 103 SPAIN: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 158
TABLE 104 REST OF EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 159
TABLE 105 REST OF EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE
MARKET, BY TYPE, 2022-2029 (USD MILLION) 159
TABLE 106 REST OF EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 160
TABLE 107 REST OF EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 160
TABLE 108 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 162
TABLE 109 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 162
TABLE 110 ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 111 ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 112 ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 113 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 164
TABLE 114 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 115 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY END USER, 2022-2029 (USD MILLION) 165
TABLE 116 JAPAN: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY 166
TABLE 117 JAPAN: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 166
TABLE 118 JAPAN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 167
TABLE 119 JAPAN: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 167
TABLE 120 JAPAN: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 167
TABLE 121 CHINA: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY 168
TABLE 122 CHINA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 169
TABLE 123 CHINA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 169
TABLE 124 CHINA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 170
TABLE 125 CHINA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 170
TABLE 126 INDIA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 171
TABLE 127 INDIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 128 INDIA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 129 INDIA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 130 AUSTRALIA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 173
TABLE 131 AUSTRALIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 132 AUSTRALIA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 133 AUSTRALIA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 134 SOUTH KOREA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 175
TABLE 135 SOUTH KOREA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 176
TABLE 136 SOUTH KOREA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 176
TABLE 137 SOUTH KOREA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 176
TABLE 138 REST OF ASIA PACIFIC: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET 177
TABLE 139 REST OF ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 178
TABLE 140 REST OF ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 141 REST OF ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE,
2022-2029 (USD MILLION) 179
TABLE 142 REST OF ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 179
TABLE 143 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 180
TABLE 144 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 180
TABLE 145 LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 146 LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 147 LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 148 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 182
TABLE 149 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 150 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY END USER, 2022-2029 (USD MILLION) 183
TABLE 151 BRAZIL: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 184
TABLE 152 BRAZIL: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 153 BRAZIL: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 154 BRAZIL: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 155 MEXICO: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 186
TABLE 156 MEXICO: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET,
BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 157 MEXICO: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 158 MEXICO: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 159 REST OF LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 188
TABLE 160 REST OF LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 161 REST OF LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE,
2022-2029 (USD MILLION) 189
TABLE 162 REST OF LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 189
TABLE 163 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY REGION, 2022-2029 (USD MILLION) 190
TABLE 164 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 191
TABLE 165 MIDDLE EAST & AFRICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 166 MIDDLE EAST & AFRICA: ICE CATHETERS MARKET, BY TYPE,
2022-2029 (USD MILLION) 192
TABLE 167 MIDDLE EAST & AFRICA: ICE CONSOLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 192
TABLE 168 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 193
TABLE 169 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 170 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY END USER, 2022-2029 (USD MILLION) 194
TABLE 171 GCC COUNTRIES: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 195
TABLE 172 GCC COUNTRIES: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 173 GCC COUNTRIES: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 174 GCC COUNTRIES: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 175 REST OF MIDDLE EAST & AFRICA (ROMEA): INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 197
TABLE 176 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 177 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CATHETERS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 178 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CONSOLES MARKET,
BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 179 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET 199
TABLE 180 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DEGREE OF COMPETITION 203
TABLE 181 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PRODUCT FOOTPRINT 208
TABLE 182 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: APPLICATION FOOTPRINT 209
TABLE 183 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: END-USER FOOTPRINT 210
TABLE 184 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: REGION FOOTPRINT 211
TABLE 185 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 214
TABLE 186 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 215
TABLE 187 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024 218
TABLE 188 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DEALS, JANUARY
2021-JUNE 2024 219
TABLE 189 MEDTRONIC: COMPANY OVERVIEW 220
TABLE 190 MEDTRONIC: PRODUCTS OFFERED 222
TABLE 191 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2020-JUNE 2024 223
TABLE 192 MEDTRONIC: DEALS, JANUARY 2020-JUNE 2024 224
TABLE 193 ABBOTT: COMPANY OVERVIEW 225
TABLE 194 ABBOTT: PRODUCTS OFFERED 226
TABLE 195 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024 227
TABLE 196 ABBOTT: DEALS, JANUARY 2020-JUNE 2024 228
TABLE 197 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 230
TABLE 198 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 231
TABLE 199 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024 232
TABLE 200 GE HEALTHCARE: COMPANY OVERVIEW 234
TABLE 201 GE HEALTHCARE: PRODUCTS OFFERED 235
TABLE 202 GE HEALTHCARE: PRODUCT APPROVALS, JANUARY 2020-JUNE 2024 236
TABLE 203 GE HEALTHCARE: DEALS, JANUARY 2020-JUNE 2024 237
TABLE 204 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 239
TABLE 205 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 240
TABLE 206 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2020-
JUNE 2024 241
TABLE 207 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2020-JUNE 2024 241
TABLE 208 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2020-JUNE 2024 242
TABLE 209 PHILIPS HEALTHCARE: COMPANY OVERVIEW 243
TABLE 210 PHILIPS HEALTHCARE: PRODUCTS OFFERED 244
TABLE 211 PHILIPS HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024 245
TABLE 212 PHILIPS HEALTHCARE: DEALS, JANUARY 2020-JUNE 2024 246
TABLE 213 PHILIPS HEALTHCARE: EXPANSIONS, JANUARY 2020-JUNE 2024 246
TABLE 214 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 248
TABLE 215 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED 249
TABLE 216 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024 250
TABLE 217 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2020-JUNE 2024 251
TABLE 218 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 252
TABLE 219 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 253
TABLE 220 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024 254
TABLE 221 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS, JANUARY 2020-JUNE 2024 254
TABLE 222 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 255
TABLE 223 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED 256
TABLE 224 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 258
TABLE 225 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 259
TABLE 226 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024 260
TABLE 227 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2020-JUNE 2024 260
TABLE 228 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 261
TABLE 229 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 262
TABLE 230 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY
2020-JUNE 2024 263
TABLE 231 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2020-JUNE 2024 263
TABLE 232 GUERBET: COMPANY OVERVIEW 264
TABLE 233 GUERBET: PRODUCTS OFFERED 265
TABLE 234 GUERBET: DEALS, JANUARY 2020-JUNE 2024 266
TABLE 235 TERUMO CORPORATION: COMPANY OVERVIEW 267
TABLE 236 TERUMO CORPORATION: PRODUCTS OFFERED 268
TABLE 237 TERUMO CORPORATION: DEALS, JANUARY 2020-JUNE 2024 269
TABLE 238 LIVANOVA: COMPANY OVERVIEW 270
TABLE 239 LIVANOVA: PRODUCTS OFFERED 271
TABLE 240 INFRAREDX INC.: COMPANY OVERVIEW 272
TABLE 241 INFRAREDX INC.: PRODUCTS OFFERED 272
TABLE 242 STEREOTAXIS, INC.: COMPANY OVERVIEW 273
TABLE 243 STEREOTAXIS, INC.: PRODUCTS OFFERED 274
TABLE 244 STEREOTAXIS, INC.: DEALS, JANUARY 2020-JUNE 2024 274
TABLE 245 B. BRAUN SE: COMPANY OVERVIEW 275
TABLE 246 B. BRAUN SE: PRODUCTS OFFERED 276
TABLE 247 ESAOTE SPA: COMPANY OVERVIEW 277
TABLE 248 ESAOTE SPA: PRODUCTS OFFERED 277
TABLE 249 ESAOTE SPA: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024 278
TABLE 250 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 279
TABLE 251 SHIFAMED, LLC: COMPANY OVERVIEW 280
TABLE 252 CONAVI MEDICAL INC.: COMPANY OVERVIEW 281
TABLE 253 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.: COMPANY OVERVIEW 281
TABLE 254 BK MEDICAL: COMPANY OVERVIEW 282
TABLE 255 BENQ MEDICAL TECHNOLOGY: COMPANY OVERVIEW 283
TABLE 256 ECHONOUS INC.: COMPANY OVERVIEW 283
TABLE 257 VOLTA MEDICAL: COMPANY OVERVIEW 284
TABLE 258 TRIVITRON HEALTHCARE: COMPANY OVERVIEW 285
TABLE 259 ECHOPIXEL: COMPANY OVERVIEW 286
TABLE 260 CATHVISION: COMPANY OVERVIEW 287
TABLE 261 PIE MEDICAL IMAGING BV: COMPANY OVERVIEW 288

FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 39
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
FIGURE 4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SIZE ESTIMATION:
APPROACH 1 (COMPANY REVENUE ESTIMATION) 41
FIGURE 5 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SIZE ESTIMATION:
BOTTOM-UP APPROACH 42
FIGURE 6 TOP-DOWN APPROACH 43
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
FIGURE 8 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS 47
FIGURE 9 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT,
2024 VS. 2029 (USD MILLION) 50
FIGURE 10 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 51
FIGURE 11 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 52
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET 53
FIGURE 13 INCREASING DEMAND FOR PREDICTIVE ANALYTICS IN ICE DEVICES-MAJOR FACTOR DRIVING INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET 54
FIGURE 14 ASIA PACIFIC REGIONAL MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 55
FIGURE 15 HOSPITALS & SURGICAL CENTERS ACCOUNTED FOR LARGEST MARKET
SHARE IN 2023 56
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 57
FIGURE 17 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
FIGURE 18 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PORTER'S FIVE FORCES MODEL 67
FIGURE 19 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: ECOSYSTEM ANALYSIS 79
FIGURE 20 NUMBER OF DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET,
2018-2022 (USD MILLION) 80
FIGURE 21 NUMBER OF INVESTOR DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY KEY PLAYER, 2018-2022 80
FIGURE 22 VALUE OF INVESTOR DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION) 81
FIGURE 23 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: VALUE CHAIN ANALYSIS 85
FIGURE 24 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: SUPPLY CHAIN ANALYSIS 86
FIGURE 25 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY PRODUCT (USD THOUSAND) 87
FIGURE 26 AVERAGE SELLING PRICE TREND OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY KEY PLAYER, 2021-2023 (USD) 88
FIGURE 27 AVERAGE SELLING PRICE TREND OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2021-2023 (USD) 88
FIGURE 28 PATENT DETAILS FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, JANUARY 2013-DECEMBER 2023 91
FIGURE 29 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 95
FIGURE 30 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: BUYING CRITERIA 96
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES 97
FIGURE 32 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SNAPSHOT 134
FIGURE 33 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SNAPSHOT 161
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET (2019-2023) 201
FIGURE 35 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SHARE ANALYSIS (2023) 202
FIGURE 36 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS) 206
FIGURE 37 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY FOOTPRINT 207
FIGURE 38 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 213
FIGURE 39 EV/EBITDA OF KEY VENDORS 216
FIGURE 40 5-YEAR STOCK BETA OF KEY VENDORS 216
FIGURE 41 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 217
FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2023) 221
FIGURE 43 ABBOTT: COMPANY SNAPSHOT (2023) 226
FIGURE 44 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 231
FIGURE 45 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 235
FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 240
FIGURE 47 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023) 244
FIGURE 48 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023) 249
FIGURE 49 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2023) 253
FIGURE 50 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023) 256
FIGURE 51 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023) 259
FIGURE 52 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023) 262
FIGURE 53 GUERBET: COMPANY SNAPSHOT (2023) 265
FIGURE 54 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 268
FIGURE 55 LIVANOVA: COMPANY SNAPSHOT (2022) 271
FIGURE 56 STEREOTAXIS, INC.: COMPANY SNAPSHOT (2023) 273
FIGURE 57 B. BRAUN SE: COMPANY SNAPSHOT (2023) 276